Toray Industries Inc (TOR1) ニュース

I don't doubt the CEO is not great. Gonna hold for a few weeks and see if anything is in the works.

Oh, I do... as multiple 10k-share purchases puts me over 600k shares total. Patiently waiting for approval and partnership(s).

What a waste of time. I couldn’t imagine drawing lines to chart.🤣😂🤣☝️😎👍🐳

My (our) analysis doesn't follow - My (our) analysis LEADS....

Right DOWN TO THE MINUTE........Just THOUSANDS of chartists ;

YOU'LL NEED TO TRY BETTER THAN THAT...

HOPING KBLB DOES WELL ISN'T AN ENDORSEMENT THAT "ANYONES MONEY IS GOOD

HERE."

THANKS FOR FEVERISHLY PERUSING THROUGH MY POSTS THOUGH,

https://external-content.duckduckgo.com/iu/?u=https%3A%2F%2Ftse3.

*****🚽MJNA💩 RUT ROH !!! Reclassification meeting earlier this week did not go well - no way MJ gets reclassified any time soon - sorry bag holders

Point in fact it will fade away till the next hype begins in 4 years - Wh👀ps

HUZZAH🤔 !!! EN

Liar. Page 70 of the decision states differently, as does the Phunware case citing the holding by magistrate Stein.

If not there should be :)

I am new here. Does anyone else see the right shoulder forming on the daily chart of NVDA?

LIES!!!!! TRY BETTER!!!! LYING DOESN'T WORK AROUND HERE....

Ken said middle of this year that each company would make their own
announcements remember? Don't blow smoke, I hear you don't like that.

Ted. or should i call you Adam.

The difference is that i know X and he knows me although there is an Atlantic ocean between us. And i trust him. why . Because he puts his money where his mouth is. why do I know that? because we are also invested in a private company together .

Article: TradingView Adds Coinbase Perpetual Swaps in Platform Expansion
Saturday, 07/12/2024 | 09:39 GMT-5 by Damian Chmiel

The charting platform has integrated Coinbase's perpetual cryptocurrency swaps, allowing users to analyze contracts on digital assets.
The

Great follow up data presented today:

https://investor.bluebirdbio.com/news-releases/news-release-details/long-term-follow-data-continue-support-beti-cel-potentially

Let’s get the clock back and Cap raise behind us, then Blue Skies ahead for blueBIRD shareholders;)

Big news better come soon or they might run out of funding lol

The fat lady will scream @ 50$

Manibiotech, you lied again.

The seeds of irrational exuberance are planted in the soil of irrational pessimism.

Executive summary. Logic, reason and real science don't have any effect on these dolts. They just KNOW the truth. Good Lord.

The sad reality about this is that although this is a great example of how asinine and unrealistic the agenda and vision of the progressive left climate fant

And tougher when on-line helpers go on strike. Sticky indeed. Will he turn out to be a lone gunman irate at the refusal of a claim by someone personally close to him. Or could be a guy who stretched the stakes while on an anarchist high. Or could it be a far-right American billionaire supporter of T

RLAY...$4.61...🥳... https://schrts.co/dAgygcri ...Bullish Matching Low Reversal Pattern to the Upside...Confirmation Candle coming off the Oversold Bottom...

Global licensing agreement grants Elevar Therapeutics worldwide rights to develop and commercialize lirafugratinib (RLY

Despite the EM, technicals still have a positive par sar on daily and weekly. A pop above .045 gets the monthly. Bollingers compressed for a pivot topside.
Just my take

'No concerns': Republican dismiss ethics issues with Musk, Ramaswamy

Elon Musk and Vivek Ramaswamy may be exempt from ethics rules as Trump's advisors

Elon Musk says DOGE can 'gut the federal government' with a recent Supreme Court ruling. Some lawyers disagree.

RLAY...$4.61...🥳... https://schrts.co/dAgygcri ...Bullish Matching Low Reversal Pattern to the Upside...Confirmation Candle coming off the Oversold Bottom...

Global licensing agreement grants Elevar Therapeutics worldwide rights to develop and commercialize lirafugratinib (RLY

RLAY...$4.61...🥳... https://schrts.co/dAgygcri ...Bullish Matching Low Reversal Pattern to the Upside...Confirmation Candle coming off the Oversold Bottom...

Global licensing agreement grants Elevar Therapeutics worldwide rights to develop and commercialize lirafugratinib (RLY

so slow